Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans

Journal of Physiology

Volumn 579, Issue 2, 2007, Pages 553-564

  Yegutkin, Gennady G ^a   Samburski, Sergei S ^a   Mortensen, Stefan P ^b   Jalkanen, Sirpa ^a   Gonfzález alonso, José ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; APYRASE; CARBON 14; HYDROLASE; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOTIDASE; NUCLEOTIDE PYROPHOSPHATASE; NUCLEOTIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; PADGEM PROTEIN; PHOSPHODIESTERASE; PHOSPHOTRANSFERASE; TRITIUM; UNCLASSIFIED DRUG; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDE;

ARTERIAL BLOOD; ARTICLE; ATHLETE; BICYCLE ERGOMETRY; BIOLUMINESCENCE; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; ENERGY RECOVERY; ENZYME BLOOD LEVEL; ENZYME RELEASE; EXERCISE; FLOW CYTOMETRY; HEART RIGHT ATRIUM; HEMOSTASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LIFESTYLE; NORMAL HUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBOSIS; UPREGULATION; VENOUS BLOOD; ADULT; BICYCLE ERGOMETER; BLOOD CLOTTING; ENDURANCE TRAINING; ENZYME ACTIVITY; MALE; PLATELET REACTIVITY; SITTING; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADULT; EXERCISE; HUMANS; HYDROLASES; MALE; NUCLEOTIDASES; P-SELECTIN; PYROPHOSPHATASES; RISK FACTORS; THROMBOSIS; VASODILATION;

EID: 33847689290     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.119453     Document Type: Article

References (48)

1. Andersen P & Saltin B (1985). Maximal perfusion of skeletal muscle in man. J Physiol 366, 233-249.
2. Atkinson B, Dwyer K, Enjyoji K & Robson SC (2006). Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis 36, 217-222.
3. Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W & Ginsberg MD (2003). Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 34, 758-763.
4. Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JH, Marcus AJ & Szeto HH (2002). Role of extracellular ATP metabolism in regulation of platelet reactivity. J Laboratory Clin Med 140, 166-175.
5. Borna C, Lazarowski E, Van Heusden C, Ohlin H & Erlinge D (2005). Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3, 10.
6. Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS & Ali NM (2005). Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model. J Thromb Thrombolysis 19, 115-122.
7. Burnstock G (2006). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58, 58-86.
8. Cauwenberghs S, Feijge MA, Hageman G, Hoylaerts M, Akkerman JW, Curvers J & Heemskerk JW (2006). Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: Importance for platelet activity during thrombus formation. Transfusion 46, 1018-1028.
9. Clifford PS & Hellsten Y (2004). Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 97, 393-403.
10. Coade SB & Pearson JD (1989). Metabolism of adenine nucleotides in human blood. Circ Res 65, 531-537.
11. Coppola A, Coppola L, dalla Mora L, Limongelli FM, Grassia A, Mastrolorenzo L, Gombos G & Lucivero G (2005). Vigorous exercise acutely changes platelet and B-lymphocyte CD39 expression. J Appl Physiol 98, 1414-1419.
12. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd & Gladwin MT (2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. [see comment also]. Nat Med 9, 1498-1505.
13. Cripps CM (1968). Rapid method for the estimation of plasma haemoglobin levels. J Clin Path 24, 110-112.
14. Donaldson SH, Picher M & Boucher RC (2002). Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 26, 209-215.
15. Edwards JD & Mayall RM (1998). Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. Crit Care Med 26, 1356-1360.
16. Ellsworth ML (2004). Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. Med Sci Sports Exerc 36, 35-41.
17. Ellsworth ML, Forrester T, Ellis CG & Dietrich HH (1995). The erythrocyte as a regulator of vascular tone. Am J Physiol Heart Circ Physiol 269, H2155-H2161.
18. El-Sayed MS (2002). Exercise and training effects on platelets in health and disease. Platelets 13, 261-266.
19. Farias M 3rd, Gorman MW, Savage MV & Feigl EO (2005). Plasma ATP during exercise: Possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol 288, H1586-H1590.
20. Furukoji E, Matsumoto M, Yamashita A, Yagi H, Sakurai Y, Marutsuka K, Hatakeyama K, Morishita K, Fujimura Y, Tamura S & Asada Y (2005). Adenovirus-mediated transfer of human placental ectonucleoside triphosphate diphosphohydrolase to vascular smooth muscle cells suppresses platelet aggregation in vitro and arterial thrombus formation in vivo. Circulation 111, 808-815.
21. Gachet C (2006). Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46, 277-300.
22. Gear AR, Suttitanamongkol S, Viisoreanu D, Polanowska-Grabowska RK, Raha S & Camerini D (2001). Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97, 937-945.
23. González-Alonso J, Olsen DB & Saltin B (2002). Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: Role of circulating ATP. Circ Res 91, 1046-1055.
24. Gorman MW, Marble DR, Ogimoto K & Feigl EO (2003). Measurement of adenine nucleotides in plasma. Luminescence 18, 173-181.
25. Heptinstall S, Johnson A, Glenn JR & White AE (2005). Adenine nucleotide metabolism in human blood -important roles for leukocytes and erythrocytes. J Thromb Haemost 3, 2331-2339.
26. Jin RC, Voetsch B & Loscalzo J (2005). Endogenous mechanisms of inhibition of platelet function. Microcirculation 12, 247-258.
27. Li N, Wallen NH & Hjemdahl P (1999). Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 100, 1374-1379.
28. McMahon TJ, Moon RE, Luschinger BP, Carraway MS, Stone AE, Stolp BW, Gow AJ, Pawloski JR, Watke P, Singel DJ, Piantadosi CA & Stamler JS (2002). Nitric oxide in the human respiratory cycle. [see comments also]. Nat Med 8, 711-717.
29. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C & Levi R (2003). Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1, 2497-2509.
30. Olearczyk JJ, Ellsworth ML, Stephenson AH, Lonigro AJ & Sprague RS (2004). Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther 309, 1079-1084.
31. Perneby C, Wallen NH, Hu H, Li N & Hjemdahl P (2004). Prothrombotic responses to exercise are little influenced by clopidogrel treatment. Thromb Res 114, 235-243.
32. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL, Marcus AJ & Maliszewski CR (2002). Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109, 1031-1040.
33. Ramamurthi A, Robson SC & Lewis RS (2001). Effects of nitric oxide (NO) and soluble nucleoside triphosphate diphosphohydrolase (NTPDase) on inhibition of platelet deposition in vitro. Thromb Res 102, 331-341.
34. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K & Enjyoji K (2005). Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 31, 217-233.
35. Rosenmeier JB, Hansen J & González-Alonso J (2004). Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558, 351-365.
36. Rowell LB (2004). Ideas about control of skeletal and cardiac muscle blood flow (1876-2003): Cycles of revision and new vision. J Appl Physiol 97, 384-392.
37. Saltin B, Radegran G, Koskolou MD & Roach RC (1998). Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 162, 421-436.
38. Shepherd JT (1983). Circulation to skeletal muscle. In Handbook of Physiology, section 2, The Cardiovascular System, vol. III, Peripheral Circulation and Organ Blood Flow, ed. Shepherd JT & Abboud FM, pp. 319-370. American Physiological Society, Bethesda, MD, USA.
39. Sorensen CE, Amstrup J, Rasmussen HN, Ankorina-Stark I & Novak I (2003). Rat pancreas secretes particulate ecto-nucleotidase CD39. J Physiol 551, 881-892.
40. Steen VM, Holmsen H & Aarbakke G (1993). The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thrombosis Haemostasis 70, 506-513.
41. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA & Westfall DP (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387, 76-79.
42. Vassort G (2001). Adenosine 5′-triphosphate: A P2-purinergic agonist in the myocardium. Physiol Rev 81, 767-806.
43. Wang JS & Cheng LJ (1999). Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation. Arteriosclerosis, Thrombosis Vascular Biol 19, 1559-1565.
44. Wang L, Olivecrona G, Gotberg M, Olsson ML, Winzell MS & Erlinge D (2005). ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 96, 189-196.
45. Yegutkin G, Bodin P & Burnstock G (2000). Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129, 921-926.
46. Yegutkin GG, Henttinen T & Jalkanen S (2001). Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J 15, 251-260.
47. Yegutkin GG, Samburski SS & Jalkanen S (2003). Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J 17, 1328-1330.
48. Yegutkin GG, Samburski SS, Jalkanen S & Novak I (2006). ATP-consuming and ATP-generating enzymes secreted by pancreas. J Biol Chem 281, 29441-29447.